These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 356180)
1. beta-lactamase insensitive or inhibitory beta-lactams: two approaches to the challenge of ampicillin-resistant E. coli. Richmond MH Scand J Infect Dis Suppl; 1978; (13):11-5. PubMed ID: 356180 [TBL] [Abstract][Full Text] [Related]
2. Beta-lactam antibiotics and beta-lactamases: two sides of a continuing story. Richmond MH Rev Infect Dis; 1979; 1(1):30-8. PubMed ID: 400938 [TBL] [Abstract][Full Text] [Related]
3. Interaction of cefdinir with beta-lactamases. Labia R; Morand A Drugs Exp Clin Res; 1994; 20(2):43-8. PubMed ID: 7924895 [TBL] [Abstract][Full Text] [Related]
4. [Distinction between beta-lactamases of immunotypes 1 or 2 using a new beta-lactam antbiotic (author's transl)]. Philippon A; Paul G; Labia R; Nevot P Ann Microbiol (Paris); 1976; 127(4):487-91. PubMed ID: 788607 [TBL] [Abstract][Full Text] [Related]
5. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics. Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768 [TBL] [Abstract][Full Text] [Related]
6. beta-lactamases in bacteroides. Nord CE; Olsson B; Dornbusch K Scand J Infect Dis Suppl; 1978; (13):27-32. PubMed ID: 28561 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory activity and resistance to hydrolysis by beta-lactamases of some (D,L)-7-(alpha-fluoroacylamino)cephalosporins. Somma S; Malabarba A; Gastaldo L; Cavalleri B Farmaco Sci; 1984 May; 39(5):463-72. PubMed ID: 6376165 [TBL] [Abstract][Full Text] [Related]
9. Beta-lactamase activity in Shigella sonnei. Prince A; Neu HC Antimicrob Agents Chemother; 1976 May; 9(5):776-9. PubMed ID: 782355 [TBL] [Abstract][Full Text] [Related]
10. The activity of cephalosporins on beta-lactamase-producing Neisseria gonorrhoeae. Phillips I; Shannon K Scand J Infect Dis Suppl; 1978; (13):23-6. PubMed ID: 98833 [TBL] [Abstract][Full Text] [Related]
11. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics]. Susić E Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687 [TBL] [Abstract][Full Text] [Related]
12. Resistance to beta-lactam antibiotics Proteus strains. Lachmajer-Lutoslawska M; Bobrowski M Acta Microbiol Pol A; 1975; 8(3):141-9. PubMed ID: 1103580 [TBL] [Abstract][Full Text] [Related]
13. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams. Neu HC Curr Clin Top Infect Dis; 1987; 8():37-61. PubMed ID: 3077281 [TBL] [Abstract][Full Text] [Related]
14. Characterization and prevalence of the different mechanisms of resistance to beta-lactam antibiotics in clinical isolates of Escherichia coli. Medeiros AA; Kent RL; O'Brien TF Antimicrob Agents Chemother; 1974 Dec; 6(6):791-801. PubMed ID: 4615632 [TBL] [Abstract][Full Text] [Related]
15. [Beta-lactamase activity of bacteria of the genus Proteus]. Shvidenko IG Antibiotiki; 1978 Mar; 23(3):223-7. PubMed ID: 246373 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin. Une T; Mitsuhashi S Arzneimittelforschung; 1977; 27(1):89-93. PubMed ID: 576821 [TBL] [Abstract][Full Text] [Related]
17. [Moxalactam: an inactivator of beta-lactamases]. Labia R Sem Hop; 1983 Jun; 59(26):1959-62. PubMed ID: 6310786 [TBL] [Abstract][Full Text] [Related]